Geode Capital Management LLC Has $5.67 Million Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Geode Capital Management LLC decreased its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 0.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 772,808 shares of the company’s stock after selling 2,673 shares during the quarter. Geode Capital Management LLC owned 1.98% of Viemed Healthcare worth $5,666,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in VMD. Thrivent Financial for Lutherans raised its holdings in shares of Viemed Healthcare by 0.6% in the third quarter. Thrivent Financial for Lutherans now owns 3,425,693 shares of the company’s stock valued at $25,110,000 after buying an additional 21,047 shares during the last quarter. Wasatch Advisors LP raised its stake in shares of Viemed Healthcare by 19.6% in the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock worth $13,552,000 after acquiring an additional 303,277 shares during the last quarter. Renaissance Technologies LLC lifted its position in shares of Viemed Healthcare by 50.9% during the second quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock worth $2,873,000 after purchasing an additional 147,900 shares in the last quarter. Raffles Associates LP grew its stake in shares of Viemed Healthcare by 11.0% during the third quarter. Raffles Associates LP now owns 402,691 shares of the company’s stock valued at $2,952,000 after purchasing an additional 40,000 shares during the last quarter. Finally, Paradigm Capital Management Inc. NY increased its holdings in shares of Viemed Healthcare by 25.0% in the second quarter. Paradigm Capital Management Inc. NY now owns 400,000 shares of the company’s stock valued at $2,620,000 after purchasing an additional 80,000 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Stock Down 0.1 %

NASDAQ:VMD opened at $8.12 on Friday. The company has a market cap of $316.17 million, a price-to-earnings ratio of 30.07 and a beta of 1.46. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The stock’s fifty day moving average price is $8.60 and its two-hundred day moving average price is $7.82. Viemed Healthcare, Inc. has a 52-week low of $6.21 and a 52-week high of $10.44.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. The company had revenue of $58.00 million for the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Insiders Place Their Bets

In related news, Director Nitin Kaushal sold 5,995 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total value of $51,437.10. Following the sale, the director now directly owns 126,843 shares in the company, valued at $1,088,312.94. This trade represents a 4.51 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the transaction, the director now directly owns 107,706 shares in the company, valued at $999,511.68. The trade was a 25.19 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 72,256 shares of company stock valued at $674,739. Company insiders own 20.00% of the company’s stock.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.